IRON seen with multiple late-stage catalysts across hematology programs
TradingView reports upcoming late-stage catalysts for IRON, including phase III data for a bitopertin program in porphyria; Selcodebart data in myelofibrosis; and first patient data for DISC-3405 in polycythemia vera.